OncologyDigital health
What this study is
The implementation of the AI-assisted radiology summary tool into clinical workflows is being conducted as part of a standard-of-care quality improvement (QI) initiative at UW Health. The evaluation of this tool's impact via structured feedback from patients and providers is being undertaken as a prospective research study.
Study details
- Sponsor
- University of Wisconsin, Madison
- Conditions
- Oncology
- Enrolling
- 2,000 people
- Starts
- 2026-02-01
- Est. completion
- 2027-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedInclusion Criteria (Patient Participants): * Age 18 years or older * Having a current or prior cancer diagnosis (any cancer type) * Has active access to the UW Health MyChart patient portal. * Receiving care at UW Health within the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology. * Undergoing imaging studies (such as CT, MRI, or PET scans) as part of routine cancer care. * Willing and able to complete electronic REDCap surveys. * For interview participation: willing to participate in a 30-45-minute phone or video interview. Inclusion Criteria (Provider Participants): Cancer care providers will be eligible to participate in this study if they meet all of the following criteria: * Faculty physician (MD or DO) practicing in the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology at UW Health. * Involved in reviewing, discussing, or sharing imaging results with patients. * Planned to gain access to the AI-assisted, patient-friendly imaging summary tool as part of clinical implementation. * Willing and able to complete electronic surveys or participate in a brief interview (\~30 minutes). Exclusion Criteria (Patients): * Are unable to provide informed consent due to cognitive impairment or other limitations, as determined by the clinical or study team. * Enrolled in an active interventional clinical trial. Patients on biospecimen, registry, or non-interventional studies are eligible. * For the Patient Interview group only: Patients with radiographic disease progression will be excluded.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUW Health
Madison, Wisconsin, United States
Recruiting
Study team
Sponsor
University of Wisconsin, Madison
Study ID 2025-1716
Principal investigator
Toby Campbell, MD
UW School of Medicine and Public Health
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.